SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CLTR COULTER PHARMACEUTICAL -- Ignore unavailable to you. Want to Upgrade?

To: biowa who wrote (483)1/15/2000 12:50:00 AM
From: WTDEC  Respond to of 666
 
biowa,

While I guess anything is possible, I'm of the view that regulators' work always expands to fill the time available. If they have 6 months, they will take 6 months.
Best regards,

Walter

PS: In our shop, I hold the title of 'Chief Skeptic'. 8-)



To: biowa who wrote (483)1/15/2000 1:15:00 AM
From: Vector1  Read Replies (1) | Respond to of 666
 
<<is there a possibility that if the situation with the FDA is as described by CLTR the review time could be significantly less than 6 months (once filed)?>>

Not a chance. Remember they have to schedule an advisory committee so they really only have 3 months.
V1


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News